BIOMAGNETICS DIAGNOSTICS CORPORATION ( BMGP )
8864 Greenback Lane, Suite E
Orangevale, CA 95662
(916) 987-7922 (fax)
BIOMAGNETICS DIAGNOSTICS CORPORATION ( BMGP ) Pink
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. Our revolutionary diagnostics system and test kit testing technology for HIV, Hepatitis, H-Pylori, HPV, Tuberculosis and many other viruses, bacterium's, toxins and diseases focuses on real-time testing for the actual presence of the virus/ toxin/ disease itself, and not for antibodies produced by the body's immune system which may take anywhere from weeks to months to appear. This allows for much earlier detection and treatment, as well as delivering the test at a fraction of current costs.
The company is positioning itself to perform clinical trials in Mexico, Thailand, India and China in the first/second quarter of 2010 followed by trials in the US and Europe.
Clayton M. Hardman, Founder, President & CEO
Dr. Hai Shiene Chen, President and founder of ACGT DNA Technologies Corporation. Stem Cell and Genetic Engineering Advisor, Chinese Corporate Development Consultant
Dr. Jose Manuel Lopez Portillo, , Director Strategic Alliances & Govn't Affairs Mexico:
Rear Admiral Udomporn Sompongse (ret.), Director Strategic Alliances and Government Affairs Thailand:
Sanjay Mishra, Ph.D., Physics, Advisor:
Kuldip Sra, Ph.D., Chemistry, Advisor:
Jaspal Singh Mahal, MS, Microbiology, Advisor:
Ninlawan (Pichayayothin) Petcharaburanin, Ph.D., Advisor:
Important Company Highlights:
Patented ultra-portable hand held rapid detecting unit shown below. Developed at Los Alamos National
Laboratory. Patent License Agreement with Los Alamos National Security given to Biomagnetics Diagnostics
with Los Alamos support including continued future developments. License was confirmed through
Los Alamos News releases mid December 2009 (links below).
Simultaneous rapid detection of multiple human and animal diseases. Various viral and bacterial pathogens
such as Malaria, TB, HIV, Hepatitus, Cholera and potentially dozens more that kill millions of people each year.
Using the above unit, minimal training is required to follow the below easy to use method.
Near 100% accuracy in minutes, instead of days or weeks at a lab.
- PATENT LICENSE AGREEMENT:
Dec 16, 2009 Los Alamos National Laboratory News Release Confirming IOBS Technology Patent License Agreement with Biomagnets Diagnostics Corporation
Businesswire copy of above release
- PATENT LINKS:
Patent - Los Alamos National Labs Biosensor (all 13 .pdf pages, Patent No.: US 7,289,207 B2)
Patent more info - Los Alamos web link about the Optical Biosensor patent
Audio Interview Dec 08, 2009 with BMGP Biomagnetics CEO Clayton Hardman
Dec 06, 2009 DD fundamentals summary - Los Alamos partnership, China TB, Kenya Malaria, cap structure, etc
Dec 03, 2009 Conference Call Summary (the CC audio replay has expired)
Oct 06, 2009 Biomagnetics Diagnostics - Emerging Growth Research Report, LLP - 50 page .pdf
Major Shareholder Charles Gregoire de Rothschild Appointed as Special Advisor to Board of Biomagnetics Diagnostics
Gates Foundation statement (in Dec 04, 2009 article) to place big bets towards innovations such as quickly detecting Malaria (paragraph 7)
(NOTE: Gates Foundation Grant Application by BMGP is discussed in the News Releases section directly below)
UPDATE - Many recent events (as of mid December, 2009) are evolving rapidly such as:
- The Los Alamos National Laboratory Patent License Agreement given to Biomagnetics, concerning their multi disease and pathogen hand held rapid detection device for humans
and animals. Los Alamos developed this battery operated portable device out of their work for Homeland Security first responders, to rapidly identify toxins and pathogens in the field.
- Recent Cholera epidemic in Kenya, with CDC and W.H.O. events occuring there in January 2010. Along with other developments in China, India and Africa.
- CEO statement in Dec 28, 2009 PR "...During the first quarter, we expect to enter into several certifications in China, India and Africa, which we believe will clearly demonstrate the superiority of our technology and testing cost profile relative to the inferior solutions currently available in today's market. In the first half we expect to expand upon our groundbreaking agreement with Los Alamos National Security, commercialize the integrated optical biosensor technology for the detection of cholera, malaria, tuberculosis and HIV/AIDS, in addition to accelerating development of the technology that will enable multiple detections from a single sample..."
Expired and archived BMGP News Releases may still be found as an iHub News copy record here: http://ih.advfn.com/p.php?pid=news&cb=1262074860&symbol=BMGP
Most recent Filings:
SEC Filings: No Data Found
Period End Date
Quarterly Report- Q1 and Q2 of 2008
Jun 30, 2008
Nov 9, 2008
Dec 31, 2007
Apr 28, 2008
Initial Company Information and Disclosure Statement- Updated issuer statement
Feb 20, 2008
Feb 21, 2008
Sept 30, 2007
Feb 15, 2008
Annual Report- 2nd Quarter 2007
Mar 31, 2007
Jan 16, 2008
Mar 31, 2007
Aug 16, 2007
Dec 31, 2006
Apr 11, 2007
Mar 31, 2006
Nov 20, 2006
Supplemental Information- Issuer Information Statement
Mar 28, 2006
Apr 11, 2006
Integrity Stock Transfer
3027 E. Sunset Road
Las Vegas, NV. 89120
64,000,000 aprx as of 12-08-2009 CEO interview
Authorized Common Shares
100,000,000 common as of 12-08-2009 CEO interview
Authorized Preferred Shares
10,000,000 preferred A shares
25,000,000 aprx as of 12-08-2009 CEO interview
Paul Hardman, IR
Last update 4.11.2010
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Rules of the board according to IHUB: